81 FR 21883 - Public Meeting of the Presidential Commission for the Study of Bioethical Issues
DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Register Volume 81, Issue 71 (April 13, 2016)
Federal Register Volume 81, Issue 71 (April 13, 2016)
| Page Range | 21883-21884 | |
| FR Document | 2016-08504 |
[Federal Register Volume 81, Number 71 (Wednesday, April 13, 2016)] [Notices] [Pages 21883-21884] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-08504] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the Presidential Commission for the Study of Bioethical Issues AGENCY: Office of the Secretary, Office of the Assistant Secretary for Health, Presidential Commission for the Study of Bioethical Issues, Department of Health and Human Services. ACTION: Notice of meeting. ----------------------------------------------------------------------- SUMMARY: The Presidential Commission for the Study of Bioethical Issues (the Commission) will conduct its twenty fifth meeting on May 3, 2016. At this meeting, the Commission will reflect on the past, present, and future impact of national bioethics advisory bodies. Topics will include the history of national bioethics advisory bodies and their contributions to health policy, perspectives about similar bodies elsewhere, and discussion about what the future holds for groups like the Commission. DATES: The meeting will take place May 3, 2016, from 9 a.m. to approximately 5 p.m. ADDRESSES: Grand Hyatt Washington Hotel, 1000 H St. NW., Washington, DC 20001 FOR FURTHER INFORMATION CONTACT: Lisa M. Lee, Executive Director, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone: 202-233- 3960. Email: [email protected]. Additional information may be obtained at www.bioethics.gov. SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given of the twenty fifth meeting of the Commission. The meeting will be open to the public with attendance limited to space available. The meeting will also be webcast at www.bioethics.gov. Under authority of Executive Order 13521, dated November 24, 2009, the President established the Commission. The Commission is an expert panel of not more than 13 members who are drawn from the fields of bioethics, science, medicine, technology, engineering, law, philosophy, theology, or other areas of the humanities or social sciences. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, [[Page 21884]] health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. The main agenda for the Commission's twenty fifth meeting is to reflect upon the role of national bioethics advisory bodies, both in the US and abroad, in the past, present, and future. The Commission welcomes input from anyone wishing to provide public comment on any issue before it. Respectful consideration of opposing views and active participation by citizens in public exchange of ideas enhances overall public understanding of the issues at hand and conclusions reached by the Commission. The Commission is particularly interested in receiving comments and questions during the meeting that are responsive to specific sessions. Written comments will be accepted in advance, during, and after the meeting and are especially welcome. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted. Written comments will be accepted by email to [email protected], or by mail to the following address: Public Commentary, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C-100, Washington, DC 20005. To accommodate as many individuals as possible, the time for each question or comment may be limited. If the number of individuals wishing to pose a question or make a comment is greater than can reasonably be accommodated during the scheduled meeting, the Commission may make a random selection. Time permitting, we will read aloud as many comments as possible. Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should notify Esther Yoo by telephone at (202) 233- 3960, or email at [email protected] at least one week in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance. Dated: March 28, 2016. Lisa M. Lee, Executive Director, Presidential Commission for the Study of Bioethical Issues. [FR Doc. 2016-08504 Filed 4-12-16; 8:45 am] BILLING CODE 4154-06-P
![Federal Register / Vol. 81, No. 71 / Wednesday, April 13, 2016 / Notices 21883
(FDA). The meeting will be open to the appropriate advisory committee meeting DEPARTMENT OF HEALTH AND
public. link. HUMAN SERVICES
Name of Committee: Circulatory Procedure: Interested persons may
System Devices Panel of the Medical Public Meeting of the Presidential
present data, information, or views,
Devices Advisory Committee. Commission for the Study of
General Function of the Committee: orally or in writing, on issues pending
Bioethical Issues
To provide advice and before the committee. Written
recommendations to the Agency on submissions may be made to the contact AGENCY: Office of the Secretary, Office
FDA’s regulatory issues. person on or before May 10, 2016. Oral of the Assistant Secretary for Health,
Date and Time: The meeting will be presentations from the public will be Presidential Commission for the Study
held on May 24, 2016, from 8 a.m. to 6 scheduled on May 24, 2016 between of Bioethical Issues, Department of
p.m. approximately 1 p.m. and 2 p.m. Those Health and Human Services.
Location: Hilton Washington DC individuals interested in making formal ACTION: Notice of meeting.
North/Gaithersburg, Salons A, B, C and oral presentations should notify the
D, 620 Perry Pkwy., Gaithersburg, MD SUMMARY: The Presidential Commission
contact person and submit a brief
20877. The hotel’s phone number is for the Study of Bioethical Issues (the
statement of the general nature of the Commission) will conduct its twenty
301–977–8900. evidence or arguments they wish to
Contact Person: Evella Washington, fifth meeting on May 3, 2016. At this
present, the names and addresses of meeting, the Commission will reflect on
Center for Devices and Radiological
proposed participants, and an the past, present, and future impact of
Health, Food and Drug Administration,
indication of the approximate time national bioethics advisory bodies.
10903 New Hampshire Ave., Bldg. 66,
Rm. 1535, Silver Spring, MD 20993– requested to make their presentation on Topics will include the history of
0002, Evella.Washington@fda.hhs.gov, or before April 28, 2016. Time allotted national bioethics advisory bodies and
301–796–6683, or FDA Advisory for each presentation may be limited. If their contributions to health policy,
Committee Information Line, 1–800– the number of registrants requesting to perspectives about similar bodies
741–8138 (301–443–0572 in the speak is greater than can be reasonably elsewhere, and discussion about what
Washington, DC area). A notice in the accommodated during the scheduled the future holds for groups like the
Federal Register about last minute open public hearing session, FDA may Commission.
modifications that impact a previously conduct a lottery to determine the DATES: The meeting will take place May
announced advisory committee meeting speakers for the scheduled open public 3, 2016, from 9 a.m. to approximately 5
cannot always be published quickly hearing session. The contact person will p.m.
enough to provide timely notice. notify interested persons regarding their ADDRESSES: Grand Hyatt Washington
Therefore, you should always check the request to speak by May 2, 2016. Hotel, 1000 H St. NW., Washington, DC
Agency’s Web site at http:// Persons attending FDA’s advisory 20001
www.fda.gov/AdvisoryCommittees/
committee meetings are advised that the FOR FURTHER INFORMATION CONTACT: Lisa
default.htm and scroll down to the
Agency is not responsible for providing M. Lee, Executive Director, Presidential
appropriate advisory committee meeting
access to electrical outlets. Commission for the Study of Bioethical
link, or call the advisory committee
FDA welcomes the attendance of the Issues, 1425 New York Avenue NW.,
information line to learn about possible
public at its advisory committee Suite C–100, Washington, DC 20005.
modifications before coming to the
meetings and will make every effort to Telephone: 202–233–3960. Email:
meeting.
Agenda: On May 24, 2016, the accommodate persons with disabilities. Lisa.Lee@bioethics.gov. Additional
committee will discuss, make information may be obtained at
If you require accommodations due to a
recommendations and vote on www.bioethics.gov.
disability, please contact AnnMarie
information related to the premarket Williams, AnnMarie.Williams@ SUPPLEMENTARY INFORMATION: Pursuant
approval application regarding St. Jude fda.hhs.gov, 301–796–5966, at least 7 to the Federal Advisory Committee Act
Medical’s AMPLATZER Patent Foramen days in advance of the meeting. of 1972, Public Law 92–463, 5 U.S.C.
Ovale (PFO) Occluder. The app. 2, notice is hereby given of the
AMPLATZER PFO Occluder is a FDA is committed to the orderly twenty fifth meeting of the Commission.
percutaneously delivered permanent conduct of its advisory committee The meeting will be open to the public
cardiac implant for PFO closure. The meetings. Please visit our Web site at with attendance limited to space
device is indicated for preventing http://www.fda.gov/ available. The meeting will also be
recurrent ischemic stroke in patients AdvisoryCommittees/ webcast at www.bioethics.gov.
who have had a cryptogenic stroke due AboutAdvisoryCommittees/ Under authority of Executive Order
to a presumed paradoxical embolism. ucm111462.htm for procedures on 13521, dated November 24, 2009, the
FDA intends to make background public conduct during advisory President established the Commission.
material available to the public no later committee meetings. The Commission is an expert panel of
than 2 business days before the meeting. Notice of this meeting is given under not more than 13 members who are
If FDA is unable to post the background the Federal Advisory Committee Act (5 drawn from the fields of bioethics,
material on its Web site prior to the U.S.C. app. 2). science, medicine, technology,
meeting, the background material will engineering, law, philosophy, theology,
asabaliauskas on DSK3SPTVN1PROD with NOTICES
be made publicly available at the Dated: April 8, 2016. or other areas of the humanities or
location of the advisory committee Jill Hartzler Warner, social sciences. The Commission
meeting, and the background material Associate Commissioner for Special Medical advises the President on bioethical
will be posted on FDA’s Web site after Programs. issues arising from advances in
the meeting. Background material is [FR Doc. 2016–08530 Filed 4–12–16; 8:45 am] biomedicine and related areas of science
available at http://www.fda.gov/ BILLING CODE 4164–01–P
and technology. The Commission seeks
AdvisoryCommittees/Calendar/ to identify and promote policies and
default.htm. Scroll down to the practices that ensure scientific research,
VerDate Sep<11>2014 17:41 Apr 12, 2016 Jkt 238001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\13APN1.SGM 13APN1](https://thefederalregister.org/doc/81_FR_21954/page/1.svg)
![21884 Federal Register / Vol. 81, No. 71 / Wednesday, April 13, 2016 / Notices
health care delivery, and technological DEPARTMENT OF HEALTH AND Dated: April 6, 2016.
innovation are conducted in a socially HUMAN SERVICES David Clary,
and ethically responsible manner. Program Analyst, Office of Federal Advisory
National Institutes of Health Committee Policy.
The main agenda for the
[FR Doc. 2016–08433 Filed 4–12–16; 8:45 am]
Commission’s twenty fifth meeting is to Center for Scientific Review; Notice of
BILLING CODE 4140–01–P
reflect upon the role of national Closed Meetings
bioethics advisory bodies, both in the
US and abroad, in the past, present, and Pursuant to section 10(d) of the
Federal Advisory Committee Act, as DEPARTMENT OF HEALTH AND
future. The Commission welcomes HUMAN SERVICES
input from anyone wishing to provide amended (5 U.S.C. App.), notice is
public comment on any issue before it. hereby given of the following meetings.
The meetings will be closed to the National Institutes of Health
Respectful consideration of opposing
public in accordance with the National Institute on Deafness and
views and active participation by provisions set forth in sections
citizens in public exchange of ideas Other Communication Disorders;
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Notice of Closed Meetings
enhances overall public understanding as amended. The grant applications and
of the issues at hand and conclusions the discussions could disclose Pursuant to section 10(d) of the
reached by the Commission. The confidential trade secrets or commercial Federal Advisory Committee Act, as
Commission is particularly interested in property such as patentable material, amended (5 U.S.C. App.), notice is
receiving comments and questions and personal information concerning hereby given of the following meetings.
during the meeting that are responsive individuals associated with the grant The meetings will be closed to the
to specific sessions. Written comments applications, the disclosure of which public in accordance with the
will be accepted in advance, during, and would constitute a clearly unwarranted provisions set forth in sections
after the meeting and are especially invasion of personal privacy. 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
welcome. Comments will be publicly as amended. The grant applications and
Name of Committee: Center for Scientific
available, including any personally Review Special Emphasis Panel; Member the discussions could disclose
identifiable or confidential business Conflict: Cellular Aspects of Spinal Cord confidential trade secrets or commercial
information that they contain. Trade Injury, Epilepsy, and other Neurological property such as patentable material,
secrets should not be submitted. Disorders and Diseases. and personal information concerning
Date: April 20, 2016. individuals associated with the grant
Written comments will be accepted by Time: 11:00 a.m. to 1:00 p.m. applications, the disclosure of which
email to info@bioethics.gov, or by mail Agenda: To review and evaluate grant would constitute a clearly unwarranted
to the following address: Public applications. invasion of personal privacy.
Commentary, Presidential Commission Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, Name of Committee: National Institute on
for the Study of Bioethical Issues, 1425 Deafness and Other Communication
(Telephone Conference Call).
New York Avenue NW., Suite C–100, Contact Person: Samuel C Edwards, Ph.D., Disorders Special Emphasis Panel; Loan
Washington, DC 20005. To IRG CHIEF, Center for Scientific Review, Repayment Program.
accommodate as many individuals as National Institutes of Health, 6701 Rockledge Date: April 18, 2016.
possible, the time for each question or Drive, Room 5210, MSC 7846, Bethesda, MD Time: 1:00 p.m. to 3:00 p.m.
comment may be limited. If the number 20892, (301) 435–1246, edwardss@ Agenda: To review and evaluate grant
csr.nih.gov. applications.
of individuals wishing to pose a Place: National Institutes of Health,
This notice is being published less than 15
question or make a comment is greater Neuroscience Center, 6001 Executive
days prior to the meeting due to the timing
than can reasonably be accommodated limitations imposed by the review and Boulevard, Rockville, MD 20852 (Telephone
during the scheduled meeting, the funding cycle. Conference Call).
Commission may make a random Contact Person: Sheo Singh, Ph.D.,
Name of Committee: Center for Scientific
selection. Time permitting, we will read Scientific Review Officer, Scientific Review
Review, Special Emphasis Panel; Calcium
Branch, Division of Extramural Activities,
aloud as many comments as possible. Channels and Retinal Mechanisms.
6001 Executive Blvd., Room 8351, Bethesda,
Date: April 22, 2016.
Anyone planning to attend the Time: 10:00 a.m. to 3:00 p.m.
MD 20892, 301–496–8683, singhs@
meeting who needs special assistance, nidcd.nih.gov.
Agenda: To review and evaluate grant
such as sign language interpretation or applications. This notice is being published less than 15
other reasonable accommodations, Place: National Institutes of Health, 6701 days prior to the meeting due to the timing
should notify Esther Yoo by telephone Rockledge Drive, Bethesda, MD 20892, limitations imposed by the review and
(Telephone Conference Call). funding cycle.
at (202) 233–3960, or email at
Contact Person: Mary Custer, Ph.D., Name of Committee: National Institute on
Esther.Yoo@bioethics.gov at least one
Scientific Review Officer, Center for Deafness and Other Communication
week in advance of the meeting. The Scientific Review, National Institutes of Disorders Special Emphasis Panel; AIED
Commission will make every effort to Health, 6701 Rockledge Drive, Room 4148, Clinical Trial Review.
accommodate persons who need special MSC 7850, Bethesda, MD 20892, (301) 435– Date: April 27, 2016.
assistance. 1164, custerm@csr.nih.gov. Time: 2:30 p.m. to 4:30 p.m.
This notice is being published less than 15 Agenda: To review and evaluate grant
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Dated: March 28, 2016. days prior to the meeting due to the timing applications.
Lisa M. Lee, limitations imposed by the review and Place: National Institutes of Health,
Executive Director, Presidential Commission funding cycle. Neuroscience Center, 6001 Executive
for the Study of Bioethical Issues. (Catalogue of Federal Domestic Assistance Boulevard, Rockville, MD 20852 (Telephone
Program Nos. 93.306, Comparative Medicine; Conference Call).
[FR Doc. 2016–08504 Filed 4–12–16; 8:45 am]
93.333, Clinical Research, 93.306, 93.333, This notice is being published less than 15
BILLING CODE 4154–06–P
93.337, 93.393–93.396, 93.837–93.844, days prior to the meeting due to the timing
93.846–93.878, 93.892, 93.893, National limitations imposed by the review and
Institutes of Health, HHS) funding cycle.
VerDate Sep<11>2014 17:41 Apr 12, 2016 Jkt 238001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\13APN1.SGM 13APN1](https://thefederalregister.org/doc/81_FR_21954/page/2.svg)
Document Created: 2016-04-13 03:10:32
Document Modified: 2016-04-13 03:10:32
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of meeting. | |
| Dates | The meeting will take place May 3, 2016, from 9 a.m. to approximately 5 p.m. | |
| Contact | Lisa M. Lee, Executive Director, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone: 202-233- 3960. Email: [email protected] Additional information may be obtained at www.bioethics.gov. | |
| FR Citation | 81 FR 21883 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR